Travellers' diarrhoea antibiotic positive in Phase III
This article was originally published in Scrip
Executive Summary
Cosmo Pharmaceuticals and its US partner Santarus have reported top-line data from a Phase III trial of rifamycin SV MMX for travellers' diarrhoea showing that the study met its primary endpoints.